This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Feb 1;20(3):879-80.

doi: 10.1200/JCO.2002.20.3.879.

Meeting highlights: International Consensus Panel on the treatment of primary breast cancer

PMID: 11821479
DOI: 10.1200/JCO.2002.20.3.879

Comment

Meeting highlights: International Consensus Panel on the treatment of primary breast cancer

Richard R Love. J Clin Oncol. 2002.

. 2002 Feb 1;20(3):879-80.

doi: 10.1200/JCO.2002.20.3.879.

Author

PMID: 11821479
DOI: 10.1200/JCO.2002.20.3.879

No abstract available

PubMed Disclaimer

Comment on

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.
Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R; Combined Hormone Agents Trialists' Group and the European Organization for Research and Treatment of Cancer. Klijn JG, et al. J Clin Oncol. 2001 Jan 15;19(2):343-53. doi: 10.1200/JCO.2001.19.2.343. J Clin Oncol. 2001. PMID: 11208825
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Goldhirsch A, et al. J Clin Oncol. 2001 Sep 15;19(18):3817-27. doi: 10.1200/JCO.2001.19.18.3817. J Clin Oncol. 2001. PMID: 11559719 Review. No abstract available.

Similar articles

Meeting highlights: International consensus panel on the treatment of primary breast cancer.
Love RR. Love RR. J Clin Oncol. 2002 Apr 1;20(7):1955-6; author reply 1956-7. doi: 10.1200/JCO.2002.20.7.1955. J Clin Oncol. 2002. PMID: 11919263 No abstract available.
[Hormonal therapy of breast cancer].
Espié M. Espié M. Bull Cancer. 1994;81(10 Suppl):5-7. Bull Cancer. 1994. PMID: 7718950 Review. French. No abstract available.
Adjuvant endocrine therapy of breast cancer.
Trudeau ME, Pritchard KI. Trudeau ME, et al. Cancer Treat Res. 1992;60:69-114. doi: 10.1007/978-1-4615-3496-9_4. Cancer Treat Res. 1992. PMID: 1356002 Review. No abstract available.
Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer.
Mathew A, Davidson NE. Mathew A, et al. Breast. 2015 Nov;24 Suppl 2:S120-5. doi: 10.1016/j.breast.2015.07.027. Breast. 2015. PMID: 26255743 Review.
Ovarian ablation as a treatment for breast cancer.
Sainsbury R. Sainsbury R. Surg Oncol. 2003 Dec;12(4):241-50. doi: 10.1016/j.suronc.2003.11.002. Surg Oncol. 2003. PMID: 14998564 Review.

See all similar articles

Cited by

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients.
Tanis PJ, Nieweg OE, Valdés Olmos RA, Peterse JL, Rutgers EJ, Hoefnagel CA, Kroon BB. Tanis PJ, et al. Br J Cancer. 2002 Sep 23;87(7):705-10. doi: 10.1038/sj.bjc.6600359. Br J Cancer. 2002. PMID: 12232750 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information